Evaluation of the effectiveness of topical product containing henna and turmeric with Persian medicine based formulation in patients with contact dermatitis. Triple-blind clinical trial
- Conditions
- contact dermatitis.Irritant contact dermatitis
- Registration Number
- IRCT20220321054336N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 33
Age 18 years and above
Acute or recurrent contact dermatitis in a person with a history of mild to moderate contact dermatitis (baseline Three Item Severity score in the range of 1 to 6)
• Declare the written consent of the patient to participate in the study and the desire to attend regular treatment and follow-up courses
• Have a minimum score of one for the redness and itching option in the Three Item Severity score
Other types of dermatitis except contact dermatitis
Use of topical dermatitis medications (except moisturizers) in the last 2 weeks or systemic medications in the last 4 weeks
Taking steroids or systemic immunosuppressants with any indication
• Pregnant and lactating women
• Severe contact dermatitis (Three Item Severity = 9)
• Alcohol or drug addiction
• Heart disease, kidney disease or asthma
• Active skin disease other than contact dermatitis
• History of allergies to topical medications or cosmetics (with documentation)
Tattooing, scarring, and hyperpigmentation at the lesion site
History of any malignant disease or active cancer
G6PD enzyme deficiency
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method